RENALYTIX AI, INC.
Clinical Medical Laboratory · NEW YORK, NY
Organization Active NPI 1700420361
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 438 | 439 | $532,850 | $406,876 | $406,876 |
| 2023 | 359 | 359 | $430,800 | $332,569 | $332,569 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 0407U | Measurement of soluble tumor necrosis factor receptor 1 (stnfr1), soluble tumor necrosis receptor 2 (stnfr2), and kidney injury molecule 1 (kim-1) to evaluate risk of progressive decline in kidney function in diabetic chronic kidney disease | 267 | $924 | $924 |
| 0105U | Measurement of tumor necrosis factor receptor 1a, receptor superfamily 2 (tnfr1, tnfr2), and kidney injury molecule-1 (kim-1) in plasma to evaluate risk of rapid kidney function decline | 172 | $931 | $931 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Clinical Medical Laboratory | 291U00000X | ✓ | — | — |
Other Clinical Medical Laboratory providers in New York
- NPI 1033864756
- NPI 1104398759
- NPI 1134191927
- NPI 1689794109
- NPI 1942505904
- NPI 1568399087
- NPI 1629024559
- NPI 1265184584
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.